WCM Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $185M | Sell |
2,653,082
-1,349,988
| -34% | -$94.3M | 0.42% | 38 |
|
|
2025
Q1 | $295M | Buy |
4,003,070
+272,537
| +7% | +$20.1M | 0.76% | 37 |
|
|
2024
Q4 | $245M | Sell |
3,730,533
-207,929
| -5% | -$13.6M | 0.58% | 43 |
|
|
2024
Q3 | $306M | Sell |
3,938,462
-47,824
| -1% | -$3.71M | 0.69% | 43 |
|
|
2024
Q2 | $312M | Buy |
3,986,286
+902,255
| +29% | +$70.5M | 0.74% | 41 |
|
|
2024
Q1 | $209M | Buy |
3,084,031
+49,777
| +2% | +$3.37M | 0.5% | 43 |
|
|
2023
Q4 | $204M | Sell |
3,034,254
-1,963,451
| -39% | -$132M | 0.56% | 39 |
|
|
2023
Q3 | $338M | Sell |
4,997,705
-103,532
| -2% | -$7.01M | 0.99% | 35 |
|
|
2023
Q2 | $365M | Sell |
5,101,237
-46,628
| -0.9% | -$3.34M | 1.09% | 33 |
|
|
2023
Q1 | $357M | Buy |
5,147,865
+476,480
| +10% | +$33.1M | 1.14% | 31 |
|
|
2022
Q4 | $317M | Sell |
4,671,385
-174,449
| -4% | -$11.8M | 1.06% | 30 |
|
|
2022
Q3 | $266M | Buy |
4,845,834
+4,841,227
| +105,084% | +$266M | 0.96% | 35 |
|
|
2022
Q2 | $309K | Sell |
4,607
-697
| -13% | -$46.7K | ﹤0.01% | 200 |
|
|
2022
Q1 | $352K | Buy |
5,304
+449
| +9% | +$29.8K | ﹤0.01% | 196 |
|
|
2021
Q4 | $283K | Buy |
4,855
+362
| +8% | +$21.1K | ﹤0.01% | 201 |
|
|
2021
Q3 | $270K | Buy |
4,493
+84
| +2% | +$5.05K | ﹤0.01% | 201 |
|
|
2021
Q2 | $264K | Buy |
+4,409
| New | +$264K | ﹤0.01% | 194 |
|